|
Dr.
Georgia Dunston is a professor
in the College of Medicine
at Howard University.
Dunston, who has been with
the University since 1972,
is also the former Chair of
the Department of Microbiology.
Her research interests are
the biomedical significance
of genetic variation in African-Americans
and dedication to increasing
minority participation in
human genetic research.
These interests led to the
establishment of the Human
Immunogenetics Laboratory
at Howard in 1985, where she
has served as founder and
director of this core component
of the National Institutes
of Health (NIH) funded Research
Centers in Minority Institutions
Interdisciplinary Program.
Dunston
has been instrumental in increasing
knowledge on human leukocyte
antigen (HLA) polymorphisms
in African-Americans.
Her research examines the
impact of population differences
in HLA variation on donor/recipient
matching in clinical transportation
and gene-based differences
in the immune response to
organ transplants. Dunston’s
research on the biomedical
significance of human genome
polymorphisms has been the
vanguard of current efforts
at Howard University to build
national and international
research collaborations focusing
on genome-wide studies of
diseases common in both African-Americans
and people in the African
Diaspora. This research
has provided the scientific
foundation for formation of
the National Human Genome
Center (NHGC) at Howard University
with Dunston as the founding
director.
In
addition to her research and
role as an educator, Dunston
is a frequent speaker at universities
and conferences throughout
the U.S. and abroad; has several
publications on HLA variation
and disease associations in
African-Americans; and has
served on several national
scientific councils and committees.
Dunston earned a bachelor’s
degree in biology from Norfolk
State University, a master’s
degree in biology from Tuskegee
University, and a PhD in human
genetics from the University
of Michigan. She also
conducted postdoctoral work
in tumor immunology at NIH
in the National Cancer Institute.
|